The commercial successes of the biopharmaceutical industry over the past 20 years are a reflection of a maturing industry whose increasing focus on efficiency and cost effectiveness will expand the adoption of digital technologies into knowledge management, process/cost optimization, and manufacturing. The ultimate goal continues to be reducing costs to manufacture effective medicines efficiently and broaden patient access to life-saving drugs. Here, we review the journey of bioprocess cost models and how they have helped the industry build process knowledge…
